Company / Goodwill
United Therapeutics Goodwill History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$32.3M
FY2025
5-year range
$28.0M / $33.7M
FY2021-FY2025
Trend
+0.0%
vs FY2024
Sector context
#50 of 74
Health Care
What the data says
At $32M, United Therapeutics's goodwill ranks #50 of 74 in the Health Care sector. Declined from $34M to $32M over the past 2 years.
Based on SEC 10-K filings.
$32M in FY2025 with a 5-year CAGR of +2.9%.
Declined from $34M to $32M over the past 2 years.
Health Care sector context is included.
Goodwill over time
Growth rates
- 3-Year CAGR
- +4.9%
- 5-Year CAGR
- +2.9%
- 10-Year CAGR
- -
Sector benchmark
#50 of 74 in Health CareTop 68% of 74This company $32.3M Sector average $4.0B
▼
-99.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +2.9%, indicating consistent growth.
- In FY2025, goodwill increased 0.0% year-over-year.
- Ranks #50 out of 74 companies in the Health Care sector.
- Peak goodwill was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 6.00 (safe zone, above 2.9 threshold)
- Strong profit margin: 40.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $32.3M | +0.0% |
| FY2024 | $32.3M | -4.2% |
| FY2023 | $33.7M | +20.4% |
| FY2022 | $28.0M | +0.0% |
| FY2021 | $28.0M | +0.0% |
| FY2020 | $28.0M | +0.0% |
| FY2019 | $28.0M | -11.1% |
| FY2018 | $31.5M | +129.9% |
| FY2017 | $13.7M | +33.0% |
| FY2016 | $10.3M | +0.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026